← SynDRA
ALLOPURINOL
SynDRA canonical compound SYN0007579 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | XDH |
| Mechanism of action | Xanthine oxidase inhibitor |
| Indication | gout | kidney stones |
| Disease area | rheumatology | urology |
All known targets
- XDH
- ADORA2A
- HPRT1
- Xdh
- stxA
Mechanisms of action (all sources)
- Xanthine oxidase inhibitor
- XDH INHIBITOR
- Xanthine dehydrogenase inhibitor
Drug classes
- Xanthine Oxidase Inhibitors
- Antimetabolites
- Antioxidants
- Antirheumatic Agents
- Enzyme Inhibitors
- Free Radical Scavengers
- Gout Suppressants
- Noxae
- Xanthine Oxidase Inhibitor
ATC classes
- M04A · ANTIGOUT PREPARATIONS
Cross-references
Synonyms
- zyloprim
- tautomeric mixture of 1H-pyrazolo[3,4-d]pyrimidin-4-ol and 1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one
- allopurinol sodium
- Alopurinol
- Allopurinolum
- Suspendol
- Takanarumin
- BW-56-158
- NSC-101655
- NSC-1390
- Allopurinol component of duzallo
- Aloral
- Aluline 100
- Aluline 300
- Caplenal
- Cosuric
- Hamarin 100
- Hamarin 300
- Ledopur
- Lopurin
- Uricto
- Xanthomax-100
- Xanthomax-300
- Zyloprim
- Zyloric
- Zyloric-300
- Adenock
- Ailural
- Ailurial
- Allohexal
- Allohexan
- Alloprin
- Allopur
- Allopurin
- Allorin
- Allozym
- Allpargin
- Allural
Reported adverse events
- Rash
- Stevens-Johnson syndrome
- Renal failure
- Thrombocytopenia
- Infertility
- Ecchymosis
- Epistaxis
- Erythema
- Erythema multiforme
- Hepatic necrosis
- Myopathy
- Hypersensitivity
Look up ALLOPURINOL in the interactive SynDRA portal →